Dr Andrew Care from the Department of Molecular Sciences has been awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
Andrew’s fellowship will fund research looking at how biological nanoparticles can be used to better deliver anti-cancer drugs to destroy tumours.
Andrew and his team are re-engineering protein-based nanoparticles that are normally found in microorganisms, like bacteria. These re-engineered nanoparticles will be capable of carrying anti-cancer drugs to tumours inside the body. Continue reading Using nanoparticles to better target cancer tumours→
Scientists in Australia and California have worked out how to unboil an egg. It may sound like an odd discovery, but it’s changed the way scientists think about manipulating proteins, an industry worth AU$160 billion per year.
Flinders University Professor Colin Raston and his team have developed Vortex Fluid Technology – using mechanical energy, or spinning, to reverse the effects of thermal energy, or boiling.
“Trait-based ecology” enables Macquarie University’s Mark Westoby to explain patterns of species occurrence and abundance and to understand the impacts of climate change and changing patterns of land use. He received the $55,000 NSW Scientist of the Year.
Nanocapsules for drugs delivery: Frank Caruso is making miniature capsules that could better deliver drugs for cancer, AIDS and cardiovascular diseases. He won one of the 2014 Victoria Prizes for Science & Innovation worth $50,000.
Natural phenols, such as those found in chocolate, and minerals such as iron are being used to develop fast, economical drug-delivery capsules.
Frank Caruso is creating nano-packages for drug delivery. Credit: Richard Timbury, Casamento Photography
Frank Caruso and his team at The University of Melbourne are making nano-sized capsules that will encase vaccines and protect them from being broken down when entering the body. They believe that this delivery system will be biologically friendly and overcome a major challenge for medical materials: their compatibility with living systems.
One of the challenges of treating diseases such as cancer and HIV is delivering treatment with minimal damage to healthy areas.
Stubborn cancer cells play a cunning trick when faced with treatments designed to kill them—they eat themselves to survive. But Lisa Schafranek has found a way to starve the cancer cells, making them more susceptible to cancer therapy.
An edible plant seed could deliver your insulin or cancer drugs if David Craik’s research progresses as hoped. His team’s work at The University of Queensland’s Institute for Molecular Bioscience centres on cyclotides, which are a family of exceptionally stable circular proteins that occur naturally in many plants, such as violets and petunia.
Circular proteins naturally occuring in plants such as petunia have inspired David Craik’s research. Credit: The University of Queensland
Inspired by the stability and diversity of natural cyclotides, David’s team has developed a way to join the two ends of a linear protein, allowing them to create ‘designer’ cyclotides that can be incorporated into crop plants, turning them into production factories for therapeutic drugs and insecticides.
A breakthrough in the electroactive polymers used to make electrically controlled micro “artificial muscles” could be important for future drug delivery in the body, as well as a having a host of other applications.
A tiny micro ‘muscle’ made of electroactive polymer layers will bend when an electrical potential difference is applied. Credit: G. Alici et al.
The new research, conducted at the Australian National Fabrication Facility’s (ANFF) materials node at the University of Wollongong (UOW) in NSW has produced materials which, unlike earlier versions, do not need to be immersed in an electrolyte solution. They are self-sufficient and can even work in air. Continue reading Micro muscles bend to the task→
Unhealthy cells are less “squishy” than their healthy counterparts. That difference is used by a small device developed by engineers at Monash University to test living blood cells for diseases, such as malaria and diabetes. The device can then sort the cells for future culturing and experimentation without harming them.
A simulation of a red blood cell being trapped and strained for measurement in the Monash device. Credit: Yann Henon, Andreas Fouras & Greg Sheard
The patented “lab-on-a-chip” and accompanying control system has attracted considerable interest from pharmaceutical companies, according to co-inventor Dr Greg Sheard of the Department of Mechanical and Aerospace Engineering. Continue reading Health check for live cells→
Hundreds of Aussie science achievements that you can share in speeches, posts and publications
